<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rhabdomyolysis: Epidemiology and etiology</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rhabdomyolysis: Epidemiology and etiology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Rhabdomyolysis: Epidemiology and etiology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Salman Bhai, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mazen M Dimachkie, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ira N Targoff, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeremy M Shefner, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Dashe, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H31734773"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of intracellular muscle constituents into the circulation. Creatine kinase (CK) levels are typically markedly elevated, and muscle pain and myoglobinuria may be present. The severity of illness ranges from asymptomatic elevations in serum muscle enzymes to life-threatening disease associated with extreme enzyme elevations, electrolyte imbalances, and acute kidney injury.</p><p>The causes of rhabdomyolysis will be reviewed here.</p><p>Other aspects of rhabdomyolysis and related conditions are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span> <a class="medical medical_review" href="/d/html/5169.html" rel="external">Rhabdomyolysis: Clinical manifestations and diagnosis</a></p><p class="bulletIndent1"><span class="glyph">●</span> <a class="medical medical_review" href="/d/html/7227.html" rel="external">Crush-related acute kidney injury</a></p><p class="bulletIndent1"><span class="glyph">●</span> <a class="medical medical_review" href="/d/html/358.html" rel="external">Acute compartment syndrome of the extremities</a></p><p class="bulletIndent1"><span class="glyph">●</span> <a class="medical medical_review" href="/d/html/14034.html" rel="external">Clinical features and diagnosis of heme pigment-induced acute kidney injury</a></p><p class="bulletIndent1"><span class="glyph">●</span> <a class="medical medical_review" href="/d/html/14036.html" rel="external">Prevention and treatment of heme pigment-induced acute kidney injury (including rhabdomyolysis)</a></p><p></p><p class="headingAnchor" id="H31734780"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>The clinical manifestations and complications of rhabdomyolysis result from muscle cell death, which may be triggered by any of a variety of initiating events. The final common pathway for injury is an increase in intracellular free ionized cytoplasmic and mitochondrial calcium. This may be caused by depletion of adenosine triphosphate (ATP), the cellular source of energy, and/or by direct injury and rupture of the plasma membrane [<a href="#rid1">1,2</a>]. The latter pathway of injury also results in ATP depletion.</p><p>The increased intracellular calcium leads to activation of proteases, increased skeletal muscle cell contractility, mitochondrial dysfunction, and the production of reactive oxygen species, resulting in skeletal muscle cell death [<a href="#rid1">1</a>]. ATP depletion causes dysfunction of the Na<sup>+</sup>/K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-ATPase pumps that are essential to maintaining integrity of the myocyte. ATP depletion leads to myocyte injury and the release of intracellular muscle constituents, including creatine kinase (CK) and other muscle enzymes, myoglobin, and various electrolytes. Myoglobin contains heme, which is nephrotoxic. (See  <a class="medical medical_review" href="/d/html/14034.html" rel="external">"Clinical features and diagnosis of heme pigment-induced acute kidney injury", section on 'Pathogenesis'</a>.)</p><p class="headingAnchor" id="H31734787"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>There are multiple potential causes of rhabdomyolysis [<a href="#rid3">3-7</a>]; these can be broadly divided into three categories related to mechanism of injury  (<a class="graphic graphic_table graphicRef60404" href="/d/graphic/60404.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic or muscle compression (eg, crush syndrome or prolonged immobilization)</p><p class="bulletIndent1"><span class="glyph">●</span>Nontraumatic exertional (eg, marked exertion in untrained individuals, eccentric exercises, hyperthermia, or metabolic and other myopathies)</p><p class="bulletIndent1"><span class="glyph">●</span>Nontraumatic nonexertional (eg, drugs or toxins, infections, or electrolyte disorders)</p><p></p><p>Rhabdomyolysis can also be classified as acquired (eg, trauma, drugs, physical exertion) or inherited (eg, muscular dystrophies, metabolic and mitochondrial disorders, sickle cell trait).</p><p>The specific cause is frequently evident from the history or from the immediate circumstances preceding the disorder, such as crush injury, comatose or postictal state, postoperative surgical trauma, or extraordinary physical exertion, as in status epilepticus for example. In other cases, the precipitant may not be as immediately evident but is identified through a careful history, physical examination, and laboratory evaluation [<a href="#rid4">4,5,8</a>]. The specific causes within each of the three major categories are discussed in detail in the sections below. (See <a class="local">'Trauma or direct muscle injury'</a> below and <a class="local">'Nontraumatic exertional'</a> below and <a class="local">'Nonexertional and nontraumatic'</a> below.)</p><p class="headingAnchor" id="H3220770590"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H1167524576"><span class="h2">Incidence</span><span class="headingEndMark"> — </span>The true incidence of rhabdomyolysis is unknown, mainly due to its highly variable presentation and underrecognition and reporting of mild cases [<a href="#rid9">9</a>]. In the United States, there are approximately 26,000 cases of rhabdomyolysis reported each year [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H880591726"><span class="h2">Common causes</span></p><p class="headingAnchor" id="H984971681"><span class="h3">Adult</span><span class="headingEndMark"> — </span>Trauma, infections, drugs (illicit, prescribed, and alcohol), and surgery are the most common causes of rhabdomyolysis reported in adults [<a href="#rid4">4,11-16</a>].</p><p>In a study that included 2371 patients with rhabdomyolysis, the most frequently associated clinical conditions included trauma (26 percent), immobilization (18 percent), sepsis (10 percent), vascular surgery (8 percent), and cardiac surgery (6 percent) [<a href="#rid11">11</a>]. In another series of 475 patients, the most common causes were exogenous toxins (46 percent), including alcohol and illicit drugs (34 percent) and medical drugs (11 percent) [<a href="#rid4">4</a>]. Up to 60 percent of patients had more than one etiologic factor. Underlying myopathy or muscle metabolic defects were seen in 10 percent of the cases, in which there was a higher rate of recurrence and only one etiologic factor. No cause was identified in 7 percent of patients.</p><p>Differences in the reported frequencies and the causes of rhabdomyolysis between these studies are likely related to differences in case ascertainment and populations studied.</p><p class="headingAnchor" id="H4058796392"><span class="h3">Pediatric</span><span class="headingEndMark"> — </span>Infections, inherited conditions, and exercise/physical exertion are the most common causes of rhabdomyolysis reported in children [<a href="#rid12">12,17-19</a>].</p><p class="headingAnchor" id="H112024759"><span class="h3">Recurrent rhabdomyolysis</span><span class="headingEndMark"> — </span>Recurrence of rhabdomyolysis is most often associated with inherited metabolic muscle conditions. (See <a class="local">'Inherited disorders'</a> below.)</p><p class="headingAnchor" id="H2391451189"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Risk factors for rhabdomyolysis identified in various studies include [<a href="#rid9">9,12,13,20-24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Male sex</p><p class="bulletIndent1"><span class="glyph">●</span>Black race</p><p class="bulletIndent1"><span class="glyph">●</span>Age &lt;10 years and &gt;60 years</p><p class="bulletIndent1"><span class="glyph">●</span>Body mass index &gt;40 kg/m<sup>2</sup></p><p class="bulletIndent1"><span class="glyph">●</span>History of prior heat injury</p><p class="bulletIndent1"><span class="glyph">●</span>Low premorbid physical fitness</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic use of lipid-lowering drugs</p><p class="bulletIndent1"><span class="glyph">●</span>Dehydration</p><p></p><p class="headingAnchor" id="H31734794"><span class="h1">TRAUMA OR DIRECT MUSCLE INJURY</span><span class="headingEndMark"> — </span>Trauma or muscle compression is a common cause of rhabdomyolysis and can be seen in the following settings:</p><p class="headingAnchor" id="H2183158289"><span class="h2">Crush syndrome</span><span class="headingEndMark"> — </span>A crush syndrome describes muscle destruction caused by direct trauma, injury, or compression [<a href="#rid13">13,25</a>]. It is observed in victims of multiple trauma, including individuals trapped in cars after crashes or in collapsed buildings from man-made and natural disasters (eg, wars, earthquakes, hurricanes, tsunamis) [<a href="#rid25">25-29</a>]. Many of these patients also experience a compartment syndrome. (See  <a class="medical medical_review" href="/d/html/7227.html" rel="external">"Crush-related acute kidney injury"</a> and  <a class="medical medical_review" href="/d/html/17032.html" rel="external">"Severe crush injury in adults"</a> and  <a class="medical medical_review" href="/d/html/15150.html" rel="external">"Severe lower extremity injury in the adult patient"</a> and  <a class="medical medical_review" href="/d/html/15235.html" rel="external">"Severe upper extremity injury in the adult patient"</a>.)</p><p class="headingAnchor" id="H3194477800"><span class="h2">Prolonged immobilization</span><span class="headingEndMark"> — </span>Prolonged immobilization due to coma of any cause, sedation or incapacitation (eg, drug intoxication, stroke, hip fracture), or surgery can cause rhabdomyolysis from unrelieved pressure on body regions [<a href="#rid30">30,31</a>].</p><p class="headingAnchor" id="H2537149005"><span class="h2">Compression of blood vessels</span><span class="headingEndMark"> — </span>Application of tourniquets, surgical clamps, splints, or even pneumatic compression devices can cause muscle ischemia with development of rhabdomyolysis [<a href="#rid32">32,33</a>].</p><p class="headingAnchor" id="H2508696590"><span class="h2">Surgery</span><span class="headingEndMark"> — </span>Rhabdomyolysis can develop as a complication of surgical procedures in which there is either prolonged muscle compression due to positioning [<a href="#rid34">34-36</a>] or prolonged vascular occlusion (eg, prolonged clamping) causing muscle ischemia [<a href="#rid34">34,37</a>]. (See  <a class="medical medical_review" href="/d/html/94593.html" rel="external">"Patient positioning for surgery and anesthesia in adults"</a>.)</p><p class="headingAnchor" id="H2723076330"><span class="h2">Compartment syndrome</span><span class="headingEndMark"> — </span>Rhabdomyolysis can occur in association with severe lower extremity injury (eg, tibial fracture) complicated by compartment syndrome, or arterial ischemia followed by reperfusion injury leading to compartment syndrome. Muscle injury itself can lead to muscle edema and thereby cause compartment syndrome with blood flow limitation and a vicious cycle of worsening tissue necrosis [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Epidemiology and risk factors'</a> and  <a class="medical medical_review" href="/d/html/116596.html" rel="external">"Pathophysiology, classification, and causes of acute extremity compartment syndrome"</a>.)</p><p class="headingAnchor" id="H1998153242"><span class="h2">Electrical injury and severe burn injury</span><span class="headingEndMark"> — </span>High-voltage electrical injury (eg, from lightning or high-voltage power supplies) or extensive third-degree burns can cause rhabdomyolysis via direct myofibrillar injury [<a href="#rid2">2,39,40</a>]. (See  <a class="medical medical_review" href="/d/html/175.html" rel="external">"Electrical injuries and lightning strikes: Evaluation and management"</a>.)</p><p class="headingAnchor" id="H8572518"><span class="h2">Physical restraint</span><span class="headingEndMark"> — </span>Rhabdomyolysis has been associated with individuals struggling against restraints, such as torture victims or abused children [<a href="#rid41">41-44</a>].</p><p class="headingAnchor" id="H31734801"><span class="h1">NONTRAUMATIC EXERTIONAL</span><span class="headingEndMark"> — </span>Rhabdomyolysis occurs when the energy supply to muscle is insufficient to meet demands. Examples include extreme exertion or exertion under conditions in which muscle energy production is impaired, including inherited muscle disorders.</p><p class="headingAnchor" id="H664206601"><span class="h2">Physical exertion and exercise</span><span class="headingEndMark"> — </span>Rhabdomyolysis may arise from physical exertion, particularly when one or more of the following risk factors is present:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prolonged, strenuous, or unaccustomed activity</strong> – Physical activity that is strenuous or prolonged may cause rhabdomyolysis, even in trained individuals or in the absence of other known risk factors [<a href="#rid45">45-50</a>]. The performance of unaccustomed, intense exercise also increases the risk of rhabdomyolysis (eg, a deconditioned individual joining an indoor cycling class). Subclinical myoglobinemia, myoglobinuria, and elevation in serum creatine kinase (CK) are common following physical exertion. As an example, myoglobinemia was found in 25 of 44 participants (57 percent) in an ultramarathon race of 99 kilometers [<a href="#rid45">45</a>]. The serum CK rose 16-fold from prerace levels to a mean of 2060 units/L. Myoglobin was detected in the urine of five individuals, but acute kidney injury did not occur. In a second study, 39 percent of 337 military recruits developed myoglobinemia during the first six days of basic training, but none had pigmenturia or reported muscle symptoms [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe heat and humidity</strong> – Exertion in extremely hot, humid conditions may lead to exertional heat stroke and associated organ and tissue damage, including rhabdomyolysis. (See  <a class="medical medical_review" href="/d/html/13788.html" rel="external">"Exertional heat illness in adolescents and adults: Epidemiology, thermoregulation, risk factors, and diagnosis", section on 'Exertional heat stroke'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impaired heat loss</strong> – Rhabdomyolysis may occur when normal heat loss through sweating is impaired, as with the use of anticholinergic medications or heavy football equipment [<a href="#rid52">52,53</a>]. (See  <a class="medical medical_review" href="/d/html/176.html" rel="external">"Severe nonexertional hyperthermia (classic heat stroke) in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypokalemia</strong> – Hypokalemia caused by potassium loss from sweating can reduce vascular perfusion of muscle [<a href="#rid54">54,55</a>]. During exercise, there is normally an appropriate increase in muscle perfusion to meet enhanced energy demands. This hyperemic response is mediated in part by the release of potassium from skeletal muscle cells. The ensuing local elevation in the potassium concentration causes vasodilation, which enhances regional blood flow [<a href="#rid56">56,57</a>]. However, the cellular release of potassium is impaired by potassium depletion. As a result, there is a lesser increase in blood flow, possibly resulting in cramps, ischemic necrosis, and rhabdomyolysis [<a href="#rid56">56</a>]. Hypokalemia-induced impairment in muscle metabolism also may contribute to muscle dysfunction [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Eccentric exercise</strong> – The performance of high-force eccentric exercises increases the risk of muscle injury [<a href="#rid38">38,58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sickle cell trait</strong> – Sickle cell trait is associated with a slightly higher risk of exertional rhabdomyolysis. This issue is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7145.html" rel="external">"Sickle cell trait", section on 'Rhabdomyolysis and sudden death during strenuous physical activity'</a>.)</p><p></p><p class="headingAnchor" id="H1971326754"><span class="h2">Seizures and other hyperkinetic states</span><span class="headingEndMark"> — </span>Pathologic hyperkinetic states can lead to rhabdomyolysis in individuals with normal muscles [<a href="#rid3">3,59</a>]. Examples include:</p><p class="bulletIndent1"><span class="glyph">●</span>Grand mal seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Delirium tremens</p><p class="bulletIndent1"><span class="glyph">●</span>Psychotic agitation</p><p class="bulletIndent1"><span class="glyph">●</span>Amphetamine overdose</p><p></p><p class="headingAnchor" id="H31734808"><span class="h2">Inherited disorders</span><span class="headingEndMark"> — </span>Rhabdomyolysis may develop in patients with inherited disorders that affect muscle function, metabolism, or energy production, including [<a href="#rid60">60-63</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Glycogen metabolism disorders (eg, McArdle disease)</p><p class="bulletIndent2"><span class="glyph">•</span>Lipid metabolism disorders (eg, fatty acid oxidation disorders)</p><p class="bulletIndent2"><span class="glyph">•</span>Mitochondrial disorders</p><p class="bulletIndent2"><span class="glyph">•</span>Pathogenic gene variants that alter gene expression (eg, <em>MLIP</em>), impair muscle contraction (eg, <em>MYH1</em>), or disrupt excitation-contraction coupling and calcium handling (eg, <em>OBSCN</em>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Muscular dystrophies and congenital myopathies</p><p></p><p>The metabolic myopathies represent a very small percentage of cases of rhabdomyolysis overall but are relatively common causes among patients, particularly children, with recurrent episodes of rhabdomyolysis after exertion or starvation [<a href="#rid32">32,64,65</a>]. In a series of 77 patients evaluated for "idiopathic" myoglobinuria in whom muscle biopsies were performed, specific enzyme deficiencies were identified in 36 (47 percent) [<a href="#rid65">65</a>]. Carnitine palmitoyltransferase deficiency was the most common disorder, occurring in 17 of the 36 patients, followed by muscle phosphorylase deficiency (McArdle disease) in 10. (See  <a class="medical medical_review" href="/d/html/6197.html" rel="external">"Metabolic myopathies caused by disorders of lipid and purine metabolism", section on 'Carnitine cycle disorders'</a> and  <a class="medical medical_review" href="/d/html/2909.html" rel="external">"Myophosphorylase deficiency (glycogen storage disease V, McArdle disease)"</a>.)</p><p>"Pseudometabolic" myopathies may present with clinical symptoms similar to metabolic myopathies but are due to an underlying genetic myopathy or muscular dystrophy such as caveolinopathy, dysferlinopathy, sarcoglycanopathy, Becker muscular dystrophy, core myopathy, or nemaline myopathy [<a href="#rid66">66-70</a>]. These disorders are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6197.html" rel="external">"Metabolic myopathies caused by disorders of lipid and purine metabolism"</a> and  <a class="medical medical_review" href="/d/html/2941.html" rel="external">"Overview of inherited disorders of glucose and glycogen metabolism"</a> and  <a class="medical medical_review" href="/d/html/5151.html" rel="external">"Mitochondrial myopathies: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6190.html" rel="external">"Limb-girdle muscular dystrophy"</a> and  <a class="medical medical_review" href="/d/html/6149.html" rel="external">"Duchenne and Becker muscular dystrophy: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6150.html" rel="external">"Congenital myopathies"</a>.)</p><p>The precise mechanism of muscle necrosis in the metabolic myopathies has not yet been established, but it is likely that insufficient energy production in exercising muscle leads to depletion of ATP and creatine phosphate. The maintenance of muscle cell integrity is thereby compromised [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/d/html/6193.html" rel="external">"Approach to the metabolic myopathies", section on 'Myoglobinuria and rhabdomyolysis'</a> and  <a class="medical medical_review" href="/d/html/6212.html" rel="external">"Energy metabolism in muscle"</a> and <a class="local">'Pathophysiology'</a> above.)</p><p class="headingAnchor" id="H31734815"><span class="h2">Thermal extremes and dysregulation</span><span class="headingEndMark"> — </span>Rhabdomyolysis may occur with hyperthermia associated with exertional heat stroke (see <a class="local">'Physical exertion and exercise'</a> above). Other causes of rhabdomyolysis in the setting of temperature dysregulation or thermal extremes include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malignant hyperthermia</strong> – Rhabdomyolysis is considered a later manifestation of malignant hyperthermia (MH). Susceptibility to MH is usually due to an inherited abnormality, most commonly identified in the ryanodine receptor, that causes the unregulated passage of calcium from the sarcoplasmic reticulum into the intracellular space. The persistent elevation of calcium causes sustained muscle contraction and results in ATP depletion, which causes hyperkalemia and rhabdomyolysis. The most common MH triggers are the use of inhalation anesthetics or <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a>. However, there have been a number of reports of an MH-like event (some fatal) after strenuous exercise, exposure to hot environments, or both, unrelated to exposure to anesthetics, in patients who were MH susceptible. (See  <a class="medical medical_review" href="/d/html/403.html" rel="external">"Susceptibility to malignant hyperthermia: Evaluation and management"</a> and  <a class="medical medical_review" href="/d/html/401.html" rel="external">"Malignant hyperthermia: Diagnosis and management of acute crisis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuroleptic malignant syndrome</strong> – The neuroleptic malignant syndrome is a disorder in which high fever (with or without generalized muscle contraction or tremor) develops after exposure to neuroleptic and anti-Parkinson medications. Rhabdomyolysis has been reported [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Near drowning/hypothermia</strong> – Rhabdomyolysis with myoglobinuric acute kidney failure can occur after prolonged water immersion [<a href="#rid73">73,74</a>]. The mechanism of rhabdomyolysis in this setting may involve hypothermia with muscle injury from marked vasoconstriction or from excessive shivering and/or generalized hypoxia. (See  <a class="medical medical_review" href="/d/html/180.html" rel="external">"Drowning (submersion injuries)"</a>.)</p><p></p><p class="headingAnchor" id="H31734822"><span class="h1">NONEXERTIONAL AND NONTRAUMATIC</span><span class="headingEndMark"> — </span>Nonexertional and nontraumatic causes of rhabdomyolysis include drugs and toxins, infections, electrolyte abnormalities, endocrinopathies, inflammatory myopathies, muscular dystrophies [<a href="#rid69">69,75</a>], and others [<a href="#rid2">2,4-6</a>].</p><p class="headingAnchor" id="H31734829"><span class="h2">Drugs</span><span class="headingEndMark"> — </span>Both prescribed medications and drugs of abuse have been implicated in rhabdomyolysis [<a href="#rid4">4,76</a>].</p><p class="headingAnchor" id="H451215800"><span class="h3">Prescription medications</span><span class="headingEndMark"> — </span>The most commonly reported prescription medications associated with rhabdomyolysis are [<a href="#rid32">32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Lipid-lowering drugs (statins and fibrates)</p><p class="bulletIndent1"><span class="glyph">●</span>Psychiatric medications (antipsychotics, <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a>, serotonin-specific reuptake inhibitors, <a class="drug drug_general" data-topicid="10035" href="/d/drug information/10035.html" rel="external">valproate</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Antibiotics (protease inhibitors, <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, quinolones, amphotericin B)</p><p class="bulletIndent1"><span class="glyph">●</span>Antihistamines</p><p class="bulletIndent1"><span class="glyph">●</span>Others (<a class="drug drug_general" data-topicid="8561" href="/d/drug information/8561.html" rel="external">aminocaproic acid</a>, <a class="drug drug_general" data-topicid="8736" href="/d/drug information/8736.html" rel="external">erlotinib</a>, <a class="drug drug_general" data-topicid="9293" href="/d/drug information/9293.html" rel="external">colchicine</a>, glucocorticoids, narcotics, <a class="drug drug_general" data-topicid="10305" href="/d/drug information/10305.html" rel="external">sunitinib</a>, vasopressin)</p><p></p><p>An analysis of cases of drug-associated rhabdomyolysis reported to the US Food and Drug Administration (FDA) between 2004 and 2009 described 16,435 suspected drugs in 8610 reported cases of rhabdomyolysis, among which statin drugs were the most commonly reported [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/d/html/6833.html" rel="external">"Statin muscle-related adverse events"</a>.)</p><p class="headingAnchor" id="H2283595395"><span class="h3">Drugs of abuse</span><span class="headingEndMark"> — </span>In addition to alcohol, drugs of abuse that have been implicated as causes of rhabdomyolysis include [<a href="#rid32">32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cocaine</p><p class="bulletIndent1"><span class="glyph">●</span>Amphetamines and methamphetamines</p><p class="bulletIndent1"><span class="glyph">●</span>Heroin</p><p class="bulletIndent1"><span class="glyph">●</span>Lysergic acid diethylamide (LSD)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9623" href="/d/drug information/9623.html" rel="external">Methadone</a></p><p></p><p class="headingAnchor" id="H1069145172"><span class="h3">Mechanisms</span><span class="headingEndMark"> — </span>The prescribed and illicit drugs cause rhabdomyolysis through various mechanisms [<a href="#rid77">77,78</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immobilization</strong> – Coma induced by alcohol, opioid overdose, or other central nervous system (CNS) depressants leads to prolonged immobilization and ischemic compression or crush injury of muscle. (See <a class="local">'Trauma or direct muscle injury'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Myotoxicity</strong> – Some medications, including statins and <a class="drug drug_general" data-topicid="9293" href="/d/drug information/9293.html" rel="external">colchicine</a>, are direct myotoxins (see  <a class="medical medical_review" href="/d/html/5166.html" rel="external">"Drug-induced myopathies", section on 'Drugs causing direct myotoxicity'</a>). In addition, statins can increase the risk of rhabdomyolysis in patients with other predisposing conditions, such as hypothyroidism or an inflammatory myopathy. Muscle toxicity of statin medications is reviewed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/6833.html" rel="external">"Statin muscle-related adverse events"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malignant hyperthermia (MH)</strong> – Patients exposed to volatile anesthetic agents (eg, halothane, <a class="drug drug_general" data-topicid="8992" href="/d/drug information/8992.html" rel="external">isoflurane</a>, <a class="drug drug_general" data-topicid="9887" href="/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8891" href="/d/drug information/8891.html" rel="external">desflurane</a>) with or without administration of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> may develop MH. (See  <a class="medical medical_review" href="/d/html/401.html" rel="external">"Malignant hyperthermia: Diagnosis and management of acute crisis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug-induced energy demands</strong> – Drug-induced agitation states, drug-induced seizures, dystonic reactions, and cocaine-induced hyperthermia are associated with excess muscle energy demands. (See  <a class="medical medical_review" href="/d/html/5166.html" rel="external">"Drug-induced myopathies", section on 'Cocaine'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug-drug interactions</strong> – These may be responsible for rhabdomyolysis in some individuals. The nature of the interactions varies. As an example, some drugs interfere with the clearance of statins and lead to elevated plasma levels; offending agents include macrolide antibiotics (eg, <a class="drug drug_general" data-topicid="9418" href="/d/drug information/9418.html" rel="external">erythromycin</a> and <a class="drug drug_general" data-topicid="9273" href="/d/drug information/9273.html" rel="external">clarithromycin</a>), <a class="drug drug_general" data-topicid="9217" href="/d/drug information/9217.html" rel="external">cyclosporine</a>, <a class="drug drug_general" data-topicid="8488" href="/d/drug information/8488.html" rel="external">gemfibrozil</a>, and some protease inhibitors used in the treatment of human immunodeficiency virus (HIV) infection. (See  <a class="medical medical_review" href="/d/html/5166.html" rel="external">"Drug-induced myopathies"</a> and  <a class="medical medical_review" href="/d/html/6833.html" rel="external">"Statin muscle-related adverse events"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multiple mechanisms</strong> – In some individuals exposed to drugs, multiple mechanisms may contribute to muscle damage; as an example, rhabdomyolysis with alcohol binges may result from a combination of hypokalemia, hypophosphatemia, coma, agitation, and direct muscle toxicity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dietary supplements</strong> – Dietary supplements used for weight loss or enhanced physical performance, which typically contain multiple ingredients, are associated with rhabdomyolysis, possibly as a result of metabolic stress [<a href="#rid79">79,80</a>]. In one report, use of nutritional supplements for strength training was associated with rhabdomyolysis in otherwise healthy individuals [<a href="#rid79">79</a>].</p><p></p><p class="bulletIndent1">Nutritional supplements containing ephedra, creatine, and large doses of caffeine have been implicated, but these findings have also been reported in patients using supplements lacking these compounds [<a href="#rid80">80</a>]. Creatine is a commonly used supplement, and evidence does not support its link to increased risk of rhabdomyolysis [<a href="#rid38">38,81,82</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Isolated limb perfusion</strong> – Patients undergoing isolated limb perfusion for locally recurrent melanoma may develop rhabdomyolysis as a complication of therapy [<a href="#rid83">83,84</a>]. The degree of injury is influenced by the specific drug administered and other factors, possibly including ischemia and hyperthermia. (See  <a class="medical medical_review" href="/d/html/7607.html" rel="external">"Cutaneous melanoma: Management of local recurrence", section on 'Isolated limb perfusion'</a>.)</p><p></p><p class="headingAnchor" id="H31734836"><span class="h2">Toxins</span><span class="headingEndMark"> — </span>Rhabdomyolysis may result from exposures to toxins other than medications [<a href="#rid5">5,61</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic poisons, such as carbon monoxide, which lead to insufficient muscle energy production. (See  <a class="medical medical_review" href="/d/html/322.html" rel="external">"Carbon monoxide poisoning"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Snake venoms, which occur from certain snake bites and are most often reported from Asia, Africa, and South America [<a href="#rid85">85,86</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Insect venoms, including wasp and bee stings [<a href="#rid5">5,87,88</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Mushroom poisoning [<a href="#rid89">89-92</a>]. (See  <a class="medical medical_review" href="/d/html/16135.html" rel="external">"Clinical manifestations and evaluation of mushroom poisoning", section on 'Delayed rhabdomyolysis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>An unidentified toxin found in certain types of fish [<a href="#rid93">93-97</a>]. The development of rhabdomyolysis within 24 hours of ingesting fish is referred to as Haff disease.</p><p class="bulletIndent1"><span class="glyph">●</span>Quail poisoning from eating quails that consumed <em>Galeopsis ladanum</em> seeds, which are toxic for humans [<a href="#rid98">98</a>].</p><p></p><p class="headingAnchor" id="H31734843"><span class="h2">Infections</span><span class="headingEndMark"> — </span>Rhabdomyolysis has been associated with numerous infections, including viral, bacterial, fungal, and protozoal [<a href="#rid7">7,32,99-101</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral</strong> – Acute viral infections associated with rhabdomyolysis include influenza A and B, coxsackievirus, Epstein-Barr, herpes simplex, parainfluenza, adenovirus, echovirus, HIV, and cytomegalovirus (see  <a class="medical medical_review" href="/d/html/5165.html" rel="external">"Overview of viral myositis", section on 'Pathogenesis'</a>) [<a href="#rid100">100,102,103</a>]. The most common viral etiologies of rhabdomyolysis are influenza and HIV [<a href="#rid101">101</a>]. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), may also be associated with rhabdomyolysis [<a href="#rid104">104-108</a>]. (See  <a class="medical medical_review" href="/d/html/128323.html" rel="external">"COVID-19: Clinical features", section on 'Laboratory findings'</a>.).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial</strong> – Bacterial infections associated with rhabdomyolysis include <em>Clostridium</em>, <em>Coxiella burnetii</em> (Q fever), ehrlichiosis, <em>Escherichia coli</em>, <em>Legionella</em>, leptospirosis, <em>Mycoplasma pneumoniae</em>, <em>Salmonella</em>, staphylococcal infection, <em>Streptococcus</em>, tularemia, and bacterial pyomyositis [<a href="#rid5">5,99,109-111</a>]. The most common bacterial etiologies of rhabdomyolysis are <em>Legionella</em>, <em>Streptococcus</em>, and <em>Salmonella</em> species [<a href="#rid101">101</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Others</strong> – Malaria caused by <em>Plasmodium falciparum</em> infection has been associated with rhabdomyolysis [<a href="#rid112">112,113</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sepsis</strong> – In patients with septicemia without direct muscle infection, muscle damage may be caused by a bacterial toxin or from associated fever, rigors, and dehydration [<a href="#rid114">114,115</a>]. Toxic shock syndrome, most commonly caused by circulating streptococcal or staphylococcal exotoxins, may also result in rhabdomyolysis [<a href="#rid116">116,117</a>]. (See  <a class="medical medical_review" href="/d/html/3162.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3161.html" rel="external">"Staphylococcal toxic shock syndrome"</a>.)</p><p></p><p class="headingAnchor" id="H31734850"><span class="h2">Electrolyte disorders</span><span class="headingEndMark"> — </span>Rhabdomyolysis has been associated with a variety of electrolyte disorders, particularly hypokalemia [<a href="#rid118">118,119</a>] and hypophosphatemia [<a href="#rid120">120,121</a>]. The latter association is most often seen in patients with an alcohol use disorder and those receiving hyperalimentation without phosphate supplementation [<a href="#rid120">120</a>]. Cases associated with hyperosmolality due to diabetic ketoacidosis or nonketotic hyperglycemia have also been described, and hypophosphatemia may contribute to the risk of rhabdomyolysis in some of these patients [<a href="#rid122">122-124</a>]. (See  <a class="medical medical_review" href="/d/html/2297.html" rel="external">"Clinical manifestations and treatment of hypokalemia in adults", section on 'Severe muscle weakness or rhabdomyolysis'</a> and  <a class="medical medical_review" href="/d/html/847.html" rel="external">"Hypophosphatemia: Clinical manifestations of phosphate depletion", section on 'Skeletal and smooth muscle'</a> and  <a class="medical medical_review" href="/d/html/1795.html" rel="external">"Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment", section on 'Phosphate depletion'</a>.)</p><p>Potassium release from muscle cells during exercise normally mediates vasodilation and the appropriately increased blood flow to muscles. Decreased potassium release due to profound hypokalemia (serum potassium less than 2.5 mEq/L) may promote the development of rhabdomyolysis by decreasing blood flow to muscles in response to exertion. (See <a class="local">'Physical exertion and exercise'</a> above.)</p><p>In both hypokalemic and hypophosphatemic rhabdomyolysis, the serum potassium and phosphate levels may underestimate or mask the underlying total body depletion because of the release of these electrolytes from intracellular stores due to the myonecrosis [<a href="#rid120">120</a>].</p><p>Other electrolyte disorders have been occasionally associated with rhabdomyolysis. These include hypocalcemia [<a href="#rid125">125</a>]; hyponatremia, mostly due to primary polydipsia [<a href="#rid126">126,127</a>]; and hypernatremia [<a href="#rid128">128,129</a>].</p><p class="headingAnchor" id="H31734857"><span class="h2">Endocrine disorders</span><span class="headingEndMark"> — </span>Several endocrine disorders, including diabetes and thyroid diseases, have been associated with rhabdomyolysis, sometimes in combination with other causes. As noted in the previous section, both diabetic ketoacidosis and nonketotic hyperglycemia have been associated with rhabdomyolysis due at least in part to phosphate depletion and other electrolyte imbalances associated with this condition [<a href="#rid122">122-124</a>]. (See <a class="local">'Electrolyte disorders'</a> above.)</p><p>Hypothyroidism is frequently accompanied by myalgias and mild to moderate serum creatine kinase (CK) elevations. Hypothyroid myopathy manifests additionally with mild proximal muscle weakness, muscle hypertrophy, and myoedema. In addition, overt rhabdomyolysis has been described, and concurrent statin therapy may be a risk factor. (See  <a class="medical medical_review" href="/d/html/4837.html" rel="external">"Hypothyroid myopathy", section on 'Rhabdomyolysis'</a>.)</p><p>Rhabdomyolysis has also been infrequently described in several other endocrine disorders. These include hyperthyroidism [<a href="#rid130">130</a>] and pheochromocytoma [<a href="#rid131">131</a>].</p><p class="headingAnchor" id="H31734864"><span class="h2">Inflammatory myopathies</span><span class="headingEndMark"> — </span>Rhabdomyolysis has only rarely been described in patients with the inflammatory myopathies, dermatomyositis and polymyositis [<a href="#rid132">132-134</a>]. (See  <a class="medical medical_review" href="/d/html/5159.html" rel="external">"Clinical manifestations of dermatomyositis and polymyositis in adults"</a>.)</p><p class="headingAnchor" id="H4002443435"><span class="h2">Muscular dystrophies</span><span class="headingEndMark"> — </span>Rhabdomyolysis has also been reported as a presenting manifestation of muscular dystrophies, with a variety of causative genes. The onset of rhabdomyolysis is commonly associated with a trigger (exercise or fever) but may be unprovoked in 23 percent [<a href="#rid69">69</a>]. (See  <a class="medical medical_review" href="/d/html/6190.html" rel="external">"Limb-girdle muscular dystrophy"</a> and  <a class="medical medical_review" href="/d/html/6149.html" rel="external">"Duchenne and Becker muscular dystrophy: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H31734871"><span class="h1">OTHER UNCOMMON CONDITIONS</span><span class="headingEndMark"> — </span>Rhabdomyolysis is associated with a number of other conditions in occasional patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Reports from hospital centers in Italy have described migrants arriving from West Africa presenting with severe rhabdomyolysis and fever. Evidence of viral infections (mostly Epstein-Barr virus [EBV] and coxsackievirus) was present in one-third of cases. Other factors such as trauma, nutritional factors, toxins, and sickle cell trait may have also contributed to the development of rhabdomyolysis [<a href="#rid135">135,136</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Status asthmaticus, in which muscle injury may be due to respiratory muscle overexertion and/or generalized muscle hypoxia [<a href="#rid137">137</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The administration of nondepolarizing muscle blocking agents to critically ill intensive care unit patients who require mechanical ventilation. A hypothesis is that muscle was "primed" for such injury by the underlying disease state, the administration of high-dose glucocorticoids, or the presence of an additional factor related to the critical illness [<a href="#rid138">138</a>]. (See  <a class="medical medical_review" href="/d/html/1590.html" rel="external">"Neuromuscular blocking agents in critically ill patients: Use, agent selection, administration, and adverse effects"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The "capillary leak syndrome," a rare condition in which there are sudden, recurrent episodes of markedly increased capillary permeability, causing shifts of fluid from the intravascular to interstitial compartments. This shift leads to marked edema, limb swelling and possible compartment syndrome, hypovolemia, hypotension, and, in some cases, rhabdomyolysis [<a href="#rid139">139,140</a>]. (See  <a class="medical medical_review" href="/d/html/3919.html" rel="external">"Idiopathic systemic capillary leak syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abrupt withdrawal of the gamma-aminobutyric acid (GABA) agonist <a class="drug drug_general" data-topicid="9062" href="/d/drug information/9062.html" rel="external">baclofen</a>, particularly if given intrathecally, which can lead to severe muscle spasticity and muscle necrosis [<a href="#rid141">141,142</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TASER-associated rhabdomyolysis [<a href="#rid143">143-145</a>]. Reported cases are rare, and the risk appears to be low. The mechanism may be sustained muscle contraction with depletion of ATP, the cellular source of energy. Most reported cases had coexisting risk factors or predisposing conditions for rhabdomyolysis. (See  <a class="medical medical_review" href="/d/html/138656.html" rel="external">"Evaluation and management of injuries from conductive energy devices (eg, TASERs)", section on 'Impact of muscle contraction'</a>.)</p><p></p><p class="headingAnchor" id="H31738599"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology</strong> – Rhabdomyolysis results from muscle cell death due to direct injury of the plasma membrane or to energy depletion. The release of intracellular muscle constituents into the circulation leads to the clinical manifestations and complications of rhabdomyolysis. (See <a class="local">'Introduction'</a> above and <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification </strong>– The multiple potential causes of rhabdomyolysis can be broadly divided into three categories, which are  (<a class="graphic graphic_table graphicRef60404" href="/d/graphic/60404.html" rel="external">table 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Trauma or direct muscle injury</strong> – This category of rhabdomyolysis is seen in clinical settings that include crush syndrome (ie, direct muscle trauma, injury, or compression), prolonged immobilization, compression of blood vessels, surgery, compartment syndrome, electrical injury, severe burn injury, and physical restraint. (See <a class="local">'Trauma or direct muscle injury'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nontraumatic exertional</strong> – This category includes physical exertion and exercise (particularly when prolonged, strenuous, and/or performed in hot, humid conditions), seizures and other hyperkinetic states, inherited disorders (eg, metabolic myopathies), and thermal extremes/dysregulation (eg, exertional heat stroke, malignant hyperthermia). (See <a class="local">'Nontraumatic exertional'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nontraumatic nonexertional</strong> – This category includes prescribed and illicit drugs (eg, statins, cocaine), toxins (eg, carbon monoxide), infections (eg, influenza virus, <em>Legionella</em> species), electrolyte disorders (eg, hypokalemia), endocrine disorders (eg, diabetic ketoacidosis), and, rarely, inflammatory myopathies or muscular dystrophies. (See <a class="local">'Nonexertional and nontraumatic'</a> above.)</p><p></p><p class="bulletIndent1">The etiology of rhabdomyolysis can also be related to acquired factors (eg, trauma, drugs, physical exertion) or genetic predisposition (eg, muscular dystrophies, metabolic and mitochondrial disorders, sickle cell trait). (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Most common causes</strong> – The most common clinical conditions associated with rhabdomyolysis in adults are trauma, infections, drugs (illicit and prescribed), and surgery. The most common conditions associated with rhabdomyolysis in children are infections, inherited conditions, and exercise/physical exertion. Most patients have more than one etiologic factor, and less than 10 percent have no identifiable cause. (See <a class="local">'Common causes'</a> above.)</p><p></p><p class="headingAnchor" id="H2554804719"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Marc L Miller, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med 2007; 18:90.</a></li><li><a class="nounderline abstract_t">Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med 2009; 67:272.</a></li><li><a class="nounderline abstract_t">Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61:141.</a></li><li><a class="nounderline abstract_t">Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 2005; 84:377.</a></li><li><a class="nounderline abstract_t">Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care 2005; 9:158.</a></li><li><a class="nounderline abstract_t">Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009; 361:62.</a></li><li><a class="nounderline abstract_t">Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J 2015; 15:58.</a></li><li><a class="nounderline abstract_t">Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002; 25:332.</a></li><li><a class="nounderline abstract_t">Long B, Koyfman A, Gottlieb M. An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis. Am J Emerg Med 2019; 37:518.</a></li><li><a class="nounderline abstract_t">Graves EJ, Gillum BS. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995. Vital Health Stat 13 1997; :1.</a></li><li><a class="nounderline abstract_t">McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med 2013; 173:1821.</a></li><li><a class="nounderline abstract_t">Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care 2016; 20:135.</a></li><li><a class="nounderline abstract_t">Gupta A, Thorson P, Penmatsa KR, Gupta P. Rhabdomyolysis: Revisited. Ulster Med J 2021; 90:61.</a></li><li><a class="nounderline abstract_t">Grunau BE, Pourvali R, Wiens MO, et al. Characteristics and thirty-day outcomes of emergency department patients with elevated creatine kinase. Acad Emerg Med 2014; 21:631.</a></li><li><a class="nounderline abstract_t">Linares LA, Golomb BA, Jaojoco JA, et al. The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening. Curr Drug Saf 2009; 4:181.</a></li><li><a class="nounderline abstract_t">Rodríguez E, Soler MJ, Rap O, et al. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One 2013; 8:e82992.</a></li><li><a class="nounderline abstract_t">Elsayed EF, Reilly RF. Rhabdomyolysis: a review, with emphasis on the pediatric population. Pediatr Nephrol 2010; 25:7.</a></li><li><a class="nounderline abstract_t">Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics 2006; 118:2119.</a></li><li><a class="nounderline abstract_t">Chen CY, Lin YR, Zhao LL, et al. Clinical spectrum of rhabdomyolysis presented to pediatric emergency department. BMC Pediatr 2013; 13:134.</a></li><li><a class="nounderline abstract_t">Chakravartty S, Sarma DR, Patel AG. Rhabdomyolysis in bariatric surgery: a systematic review. Obes Surg 2013; 23:1333.</a></li><li><a class="nounderline abstract_t">Iwere RB, Hewitt J. Myopathy in older people receiving statin therapy: a systematic review and meta-analysis. Br J Clin Pharmacol 2015; 80:363.</a></li><li><a class="nounderline abstract_t">Clarkson PM, Kearns AK, Rouzier P, et al. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 2006; 38:623.</a></li><li><a class="nounderline abstract_t">Prince LK, Abbott KC, Lee JJ, et al. Creatine Kinase, Coenzyme Q10, Race, and Risk of Rhabdomyolysis. Am J Kidney Dis 2015; 66:541.</a></li><li><a class="nounderline abstract_t">Grigorian A, Gabriel V, Nguyen NT, et al. Black Race and Body Mass Index Are Risk Factors for Rhabdomyolysis and Acute Kidney Injury in Trauma. J Invest Surg 2020; 33:283.</a></li><li><a class="nounderline abstract_t">Sever MS, Lameire N, Van Biesen W, Vanholder R. Disaster nephrology: a new concept for an old problem. Clin Kidney J 2015; 8:300.</a></li><li><a class="nounderline abstract_t">Bywaters EG, Beall D. Crush Injuries with Impairment of Renal Function. Br Med J 1941; 1:427.</a></li><li><a class="nounderline abstract_t">Vanholder R, Sever MS, Erek E, Lameire N. Acute renal failure related to the crush syndrome: towards an era of seismo-nephrology? Nephrol Dial Transplant 2000; 15:1517.</a></li><li><a class="nounderline abstract_t">Sever MS, Erek E, Vanholder R, et al. The Marmara earthquake: epidemiological analysis of the victims with nephrological problems. Kidney Int 2001; 60:1114.</a></li><li><a class="nounderline abstract_t">Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin 2004; 20:171.</a></li><li><a class="nounderline abstract_t">Penn AS, Rowland LP, Fraser DW. Drugs, coma, and myoglobinuria. Arch Neurol 1972; 26:336.</a></li><li><a class="nounderline abstract_t">Szewczyk D, Ovadia P, Abdullah F, Rabinovici R. Pressure-induced rhabdomyolysis and acute renal failure. J Trauma 1998; 44:384.</a></li><li><a class="nounderline abstract_t">Cabral BMI, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon 2020; 66:101015.</a></li><li><a class="nounderline abstract_t">Türkmen İ, Esenkaya İ, Unay K, Akçal MA. Rhabdomyolysis after tourniquet use in proximal tibial osteotomy: a case report and review of the literature. Acta Orthop Traumatol Turc 2015; 49:338.</a></li><li><a class="nounderline abstract_t">Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg 1998; 186:693.</a></li><li><a class="nounderline abstract_t">Lachiewicz PF, Latimer HA. Rhabdomyolysis following total hip arthroplasty. J Bone Joint Surg Br 1991; 73:576.</a></li><li><a class="nounderline abstract_t">Biswas S, Gnanasekaran I, Ivatury RR, et al. Exaggerated lithotomy position-related rhabdomyolysis. Am Surg 1997; 63:361.</a></li><li><a class="nounderline abstract_t">Adiseshiah M, Round JM, Jones DA. Reperfusion injury in skeletal muscle: a prospective study in patients with acute limb ischaemia and claudicants treated by revascularization. Br J Surg 1992; 79:1026.</a></li><li><a class="nounderline abstract_t">Rawson ES, Clarkson PM, Tarnopolsky MA. Perspectives on Exertional Rhabdomyolysis. Sports Med 2017; 47:33.</a></li><li><a class="nounderline abstract_t">Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis following electrical injury. Semin Neurol 1995; 15:329.</a></li><li><a class="nounderline abstract_t">Stollwerck PL, Namdar T, Stang FH, et al. Rhabdomyolysis and acute renal failure in severely burned patients. Burns 2011; 37:240.</a></li><li><a class="nounderline abstract_t">Malik GH, Sirwal IA, Reshi AR, et al. Acute renal failure following physical torture. Nephron 1993; 63:434.</a></li><li><a class="nounderline abstract_t">Schwengel D, Ludwig S. Rhabdomyolysis and myoglobinuria as manifestations of child abuse. Pediatr Emerg Care 1985; 1:194.</a></li><li><a class="nounderline abstract_t">Pollanen MS. Fatal rhabdomyolysis after torture by reverse hanging. Forensic Sci Med Pathol 2016; 12:170.</a></li><li><a class="nounderline abstract_t">Peebles J, Losek JD. Child physical abuse and rhabdomyolysis: case report and literature review. Pediatr Emerg Care 2007; 23:474.</a></li><li><a class="nounderline abstract_t">Schiff HB, MacSearraigh ET, Kallmeyer JC. Myoglobinuria, rhabdomyolysis and marathon running. Q J Med 1978; 47:463.</a></li><li><a class="nounderline abstract_t">Lonka L, Pedersen RS. Fatal rhabdomyolysis in marathon runner. Lancet 1987; 1:857.</a></li><li><a class="nounderline abstract_t">Meyer M, Sundaram S, Schafhalter-Zoppoth I. Exertional and CrossFit-Induced Rhabdomyolysis. Clin J Sport Med 2021; 31:e290.</a></li><li><a class="nounderline abstract_t">Hopkins BS, Li D, Svet M, et al. CrossFit and rhabdomyolysis: A case series of 11 patients presenting at a single academic institution. J Sci Med Sport 2019; 22:758.</a></li><li><a class="nounderline abstract_t">Carneiro A, Viana-Gomes D, Macedo-da-Silva J, et al. Risk factors and future directions for preventing and diagnosing exertional rhabdomyolysis. Neuromuscul Disord 2021; 31:583.</a></li><li><a class="nounderline abstract_t">Clarkson PM. Exertional rhabdomyolysis and acute renal failure in marathon runners. Sports Med 2007; 37:361.</a></li><li><a class="nounderline abstract_t">Olerud JE, Homer LD, Carroll HW. Incidence of acute exertional rhabdomyolysis. Serum myoglobin and enzyme levels as indicators of muscle injury. Arch Intern Med 1976; 136:692.</a></li><li><a class="nounderline abstract_t">Knochel JP. Environmental heat illness. An eclectic review. Arch Intern Med 1974; 133:841.</a></li><li><a class="nounderline abstract_t">Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002; 346:1978.</a></li><li><a class="nounderline abstract_t">Knochel JP. Exertional rhabdomyolysis. N Engl J Med 1972; 287:927.</a></li><li><a class="nounderline abstract_t">Knochel JP. Neuromuscular manifestations of electrolyte disorders. Am J Med 1982; 72:521.</a></li><li><a class="nounderline abstract_t">Knochel JP, Schlein EM. On the mechanism of rhabdomyolysis in potassium depletion. J Clin Invest 1972; 51:1750.</a></li><li><a class="nounderline abstract_t">Edwards G, Dora KA, Gardener MJ, et al. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396:269.</a></li><li><a class="nounderline abstract_t">Sayers SP, Clarkson PM, Rouzier PA, Kamen G. Adverse events associated with eccentric exercise protocols: six case studies. Med Sci Sports Exerc 1999; 31:1697.</a></li><li><a class="nounderline abstract_t">Ginsberg MD, Hertzman M, Schmidt-Nowara WW. Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Ann Intern Med 1970; 73:81.</a></li><li><a class="nounderline abstract_t">Nance JR, Mammen AL. Diagnostic evaluation of rhabdomyolysis. Muscle Nerve 2015; 51:793.</a></li><li><a class="nounderline abstract_t">Harmelink M. Uncommon Causes of Rhabdomyolysis. Crit Care Clin 2022; 38:271.</a></li><li><a class="nounderline abstract_t">Cabrera-Serrano M, Ravenscroft G. Recent advances in our understanding of genetic rhabdomyolysis. Curr Opin Neurol 2022; 35:651.</a></li><li><a class="nounderline abstract_t">Cabrera-Serrano M, Caccavelli L, Savarese M, et al. Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis. Brain 2022; 145:3985.</a></li><li><a class="nounderline abstract_t">Tein I, DiMauro S, DeVivo DC. Recurrent childhood myoglobinuria. Adv Pediatr 1990; 37:77.</a></li><li><a class="nounderline abstract_t">Tonin P, Lewis P, Servidei S, DiMauro S. Metabolic causes of myoglobinuria. Ann Neurol 1990; 27:181.</a></li><li><a class="nounderline abstract_t">Bhai S. Neuromuscular notes: Diagnosing metabolic myopathies. Pract Neurol (Fort Wash Pa) 2021; :57.</a></li><li><a class="nounderline abstract_t">Tarnopolsky MA. Metabolic Myopathies. Continuum (Minneap Minn) 2016; 22:1829.</a></li><li><a class="nounderline abstract_t">Lilleker JB, Keh YS, Roncaroli F, et al. Metabolic myopathies: a practical approach. Pract Neurol 2018; 18:14.</a></li><li><a class="nounderline abstract_t">Lahoria R, Milone M. Rhabdomyolysis featuring muscular dystrophies. J Neurol Sci 2016; 361:29.</a></li><li><a class="nounderline abstract_t">Scalco RS, Gardiner AR, Pitceathly RD, et al. CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies. Neuromuscul Disord 2016; 26:504.</a></li><li><a class="nounderline abstract_t">Felig P, Wahren J. Fuel homeostasis in exercise. N Engl J Med 1975; 293:1078.</a></li><li><a class="nounderline abstract_t">Eiser AR, Neff MS, Slifkin RF. Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome. Arch Intern Med 1982; 142:601.</a></li><li><a class="nounderline abstract_t">Bonnor R, Siddiqui M, Ahuja TS. Rhabdomyolysis associated with near-drowning. Am J Med Sci 1999; 318:201.</a></li><li><a class="nounderline abstract_t">Gorelik Y, Darawshi S, Yaseen H, et al. Acute Renal Failure Following Near-Drowning. Kidney Int Rep 2018; 3:833.</a></li><li><a class="nounderline abstract_t">Wu L, Brady L, Shoffner J, Tarnopolsky MA. Next-Generation Sequencing to Diagnose Muscular Dystrophy, Rhabdomyolysis, and HyperCKemia. Can J Neurol Sci 2018; 45:262.</a></li><li><a class="nounderline abstract_t">Oshima Y. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med 2011; 50:845.</a></li><li><a class="nounderline abstract_t">Curry SC, Chang D, Connor D. Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med 1989; 18:1068.</a></li><li><a class="nounderline abstract_t">Prendergast BD, George CF. Drug-induced rhabdomyolysis--mechanisms and management. Postgrad Med J 1993; 69:333.</a></li><li><a class="nounderline abstract_t">Scroggie DA, Harris M, Sakai L. Rhabdomyolysis associated with nutritional supplement use. J Clin Rheumatol 2000; 6:328.</a></li><li><a class="nounderline abstract_t">Dehoney S, Wellein M. Rhabdomyolysis associated with the nutritional supplement Hydroxycut. Am J Health Syst Pharm 2009; 66:142.</a></li><li><a class="nounderline abstract_t">Gualano B, Roschel H, Lancha AH Jr, et al. In sickness and in health: the widespread application of creatine supplementation. Amino Acids 2012; 43:519.</a></li><li><a class="nounderline abstract_t">Persky AM, Rawson ES. Safety of creatine supplementation. Subcell Biochem 2007; 46:275.</a></li><li><a class="nounderline abstract_t">Hohenberger P, Haier J, Schlag PM. Rhabdomyolysis and renal function impairment after isolated limb perfusion--comparison between the effects of perfusion with rhTNF alpha and a 'triple-drug' regimen. Eur J Cancer 1997; 33:596.</a></li><li><a class="nounderline abstract_t">Vrouenraets BC, Klaase JM, Nieweg OE, Kroon BB. Toxicity and morbidity of isolated limb perfusion. Semin Surg Oncol 1998; 14:224.</a></li><li><a class="nounderline abstract_t">Sitprija V, Gopalakrishnakone P. Snake bite, rhabdomyolysis, and renal failure. Am J Kidney Dis 1998; 31:l.</a></li><li><a class="nounderline abstract_t">Isbister GK, Hooper MR, Dowsett R, et al. Collett's snake (Pseudechis colletti) envenoming in snake handlers. QJM 2006; 99:109.</a></li><li><a class="nounderline abstract_t">George P, Pawar B, Calton N, Mathew P. Wasp sting: an unusual fatal outcome. Saudi J Kidney Dis Transpl 2008; 19:969.</a></li><li><a class="nounderline abstract_t">Betten DP, Richardson WH, Tong TC, Clark RF. Massive honey bee envenomation-induced rhabdomyolysis in an adolescent. Pediatrics 2006; 117:231.</a></li><li><a class="nounderline abstract_t">Bedry R, Baudrimont I, Deffieux G, et al. Wild-mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med 2001; 345:798.</a></li><li><a class="nounderline abstract_t">Lee PT, Wu ML, Tsai WJ, et al. Rhabdomyolysis: an unusual feature with mushroom poisoning. Am J Kidney Dis 2001; 38:E17.</a></li><li><a class="nounderline abstract_t">Diaz JH. Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings. Crit Care Med 2005; 33:419.</a></li><li><a class="nounderline abstract_t">Saviuc P, Danel V. New syndromes in mushroom poisoning. Toxicol Rev 2006; 25:199.</a></li><li><a class="nounderline abstract_t">Zhang B, Yang G, Yu X, et al. Haff disease after eating crayfish in east China. Intern Med 2012; 51:487.</a></li><li><a class="nounderline abstract_t">Huang X, Li Y, Huang Q, et al. A past Haff disease outbreak associated with eating freshwater pomfret in South China. BMC Public Health 2013; 13:447.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Haff disease associated with eating buffalo fish--United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 47:1091.</a></li><li><a class="nounderline abstract_t">Paul V, Shamah S, Garankina O, et al. Rhabdomyolysis after fish consumption: Haff's disease. QJM 2014; 107:67.</a></li><li><a class="nounderline abstract_t">Guo B, Xie G, Li X, et al. Outbreak of Haff disease caused by consumption of crayfish (Procambarus clarkii) in nanjing, China. Clin Toxicol (Phila) 2019; 57:331.</a></li><li><a class="nounderline abstract_t">Aparicio R, Oñate JM, Arizcun A, et al. [Epidemic rhabdomyolysis due to the eating of quail. A clinical, epidemiological and experimental study]. Med Clin (Barc) 1999; 112:143.</a></li><li><a class="nounderline abstract_t">Blanco JR, Zabalza M, Salcedo J, et al. Rhabdomyolysis of infectious and noninfectious causes. South Med J 2002; 95:542.</a></li><li><a class="nounderline abstract_t">Pesik NT, Otten EJ. Severe rhabdomyolysis following a viral illness: a case report and review of the literature. J Emerg Med 1996; 14:425.</a></li><li><a class="nounderline abstract_t">Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis 1996; 22:642.</a></li><li><a class="nounderline abstract_t">O'Connor JV, Iyer SK. Myoglobinuria associated with parainfluenza type 2 infection. N Y State J Med 1982; 82:1469.</a></li><li><a class="nounderline abstract_t">Ueda K, Robbins DA, Iitaka K, Linnemann CC Jr. Fatal rhabdomyolysis associated with parainfluenza type 3 infection. Hiroshima J Med Sci 1978; 27:99.</a></li><li><a class="nounderline abstract_t">Rivas-García S, Bernal J, Bachiller-Corral J. Rhabdomyolysis as the main manifestation of coronavirus disease 2019. Rheumatology (Oxford) 2020; 59:2174.</a></li><li><a class="nounderline abstract_t">Husain R, Corcuera-Solano I, Dayan E, et al. Rhabdomyolysis as a manifestation of a severe case of COVID-19: A case report. Radiol Case Rep 2020; 15:1633.</a></li><li><a class="nounderline abstract_t">Jin M, Tong Q. Rhabdomyolysis as Potential Late Complication Associated with COVID-19. Emerg Infect Dis 2020; 26:1618.</a></li><li><a class="nounderline abstract_t">Suwanwongse K, Shabarek N. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease. Cureus 2020; 12:e7561.</a></li><li><a class="nounderline abstract_t">Buckholz AP, Kaplan A, Rosenblatt RE, Wan D. Clinical Characteristics, Diagnosis, and Outcomes of 6 Patients With COVID-19 Infection and Rhabdomyolysis. Mayo Clin Proc 2020; 95:2557.</a></li><li><a class="nounderline abstract_t">Armstrong JH. Tropical pyomyositis and myoglobinuria. Arch Intern Med 1978; 138:1145.</a></li><li><a class="nounderline abstract_t">Heller HM, Telford SR 3rd, Branda JA. Case records of the Massachusetts General Hospital. Case 10-2005. A 73-year-old man with weakness and pain in the legs. N Engl J Med 2005; 352:1358.</a></li><li><a class="nounderline abstract_t">Overmiller AC, Bitter CC. Rhabdomyolysis and Multisystem Organ Failure Due to Fulminant Ehrlichiosis Infection. Wilderness Environ Med 2021; 32:226.</a></li><li><a class="nounderline abstract_t">Knochel JP, Moore GE. Rhabdomyolysis in Malaria. N Engl J Med 1993; 329:1206.</a></li><li><a class="nounderline abstract_t">Reynaud F, Mallet L, Lyon A, Rodolfo JM. Rhabdomyolysis and acute renal failure in Plasmodium falciparum malaria. Nephrol Dial Transplant 2005; 20:847.</a></li><li><a class="nounderline abstract_t">Posner MR, Caudill MA, Brass R, Ellis E. Legionnaires' disease associated with rhabdomyolysis and myoglobinuria. Arch Intern Med 1980; 140:848.</a></li><li><a class="nounderline abstract_t">Naschitz JE, Yeshurun D, Shagrawi I. Rhabdomyolysis in pneumococcal sepsis. Am J Med 1989; 87:479.</a></li><li><a class="nounderline abstract_t">Bachhuber R, Parker RA, Bennett WM. Acute renal failure in toxic shock syndrome owing to rhabdomyolysis. Ann Clin Lab Sci 1983; 13:25.</a></li><li><a class="nounderline abstract_t">McKenna UG, Meadows JA 3rd, Brewer NS, et al. Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clin Proc 1980; 55:663.</a></li><li><a class="nounderline abstract_t">Shintani S, Shiigai T, Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur Neurol 1991; 31:396.</a></li><li><a class="nounderline abstract_t">Dominic JA, Koch M, Guthrie GP Jr, Galla JH. Primary aldosteronism presenting as myoglobinuric acute renal failure. Arch Intern Med 1978; 138:1433.</a></li><li><a class="nounderline abstract_t">Singhal PC, Kumar A, Desroches L, et al. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Med 1992; 92:458.</a></li><li><a class="nounderline abstract_t">Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med 1992; 92:455.</a></li><li><a class="nounderline abstract_t">Singhal PC, Abramovici M, Venkatesan J. Rhabdomyolysis in the hyperosmolal state. Am J Med 1990; 88:9.</a></li><li><a class="nounderline abstract_t">Wang LM, Tsai ST, Ho LT, et al. Rhabdomyolysis in diabetic emergencies. Diabetes Res Clin Pract 1994; 26:209.</a></li><li><a class="nounderline abstract_t">Casteels K, Beckers D, Wouters C, Van Geet C. Rhabdomyolysis in diabetic ketoacidosis. Pediatr Diabetes 2003; 4:29.</a></li><li><a class="nounderline abstract_t">Akmal M. Rhabdomyolysis in a patient with hypocalcemia due to hypoparathyroidism. Am J Nephrol 1993; 13:61.</a></li><li><a class="nounderline abstract_t">Cronin RE. Psychogenic polydipsia with hyponatremia: report of eleven cases. Am J Kidney Dis 1987; 9:410.</a></li><li><a class="nounderline abstract_t">Putterman C, Levy L, Rubinger D. Transient exercise-induced water intoxication and rhabdomyolysis. Am J Kidney Dis 1993; 21:206.</a></li><li><a class="nounderline abstract_t">Abramovici MI, Singhal PC, Trachtman H. Hypernatremia and rhabdomyolysis. J Med 1992; 23:17.</a></li><li><a class="nounderline abstract_t">Denman JP. Hypernatraemia and rhabdomyolysis. Med J Aust 2007; 187:527.</a></li><li><a class="nounderline abstract_t">Bennett WR, Huston DP. Rhabdomyolysis in thyroid storm. Am J Med 1984; 77:733.</a></li><li><a class="nounderline abstract_t">Shemin D, Cohn PS, Zipin SB. Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure. Arch Intern Med 1990; 150:2384.</a></li><li><a class="nounderline abstract_t">Caccamo DV, Keene CY, Durham J, Peven D. Fulminant rhabdomyolysis in a patient with dermatomyositis. Neurology 1993; 43:844.</a></li><li><a class="nounderline abstract_t">Pirovino M, Neff MS, Sharon E. Myoglobinuria and acute renal failure with acute polymyositis. N Y State J Med 1979; 79:764.</a></li><li><a class="nounderline abstract_t">Kim HW, Choi JR, Jang SJ, et al. Recurrent rhabdomyolysis and myoglobinuric acute renal failure in a patient with polymyositis. Nephrol Dial Transplant 2005; 20:2255.</a></li><li><a class="nounderline abstract_t">Odolini S, Gobbi F, Zammarchi L, et al. Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean. Int J Infect Dis 2017; 62:77.</a></li><li><a class="nounderline abstract_t">Vallone A, Marino R, Vento S. Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean to Calabria, Italy. Int J Infect Dis 2017; 63:99.</a></li><li><a class="nounderline abstract_t">Barrett SA, Mourani S, Villareal CA, et al. Rhabdomyolysis associated with status asthmaticus. Crit Care Med 1993; 21:151.</a></li><li><a class="nounderline abstract_t">Ramsay DA, Zochodne DW, Robertson DM, et al. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993; 52:387.</a></li><li><a class="nounderline abstract_t">Dolberg-Stolik OC, Putterman C, Rubinow A, et al. Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis. Chest 1993; 104:123.</a></li><li><a class="nounderline abstract_t">Balcarek P, Frosch KH, Quintel M, Stürmer KM. [Systemic capillary leak syndrome causes a compartment syndrome of both lower legs and a forearm. A case report with a review of the literature]. Unfallchirurg 2005; 108:770, 772.</a></li><li><a class="nounderline abstract_t">Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002; 83:735.</a></li><li><a class="nounderline abstract_t">Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 2004; 4:6.</a></li><li><a class="nounderline abstract_t">Sanford JM, Jacobs GJ, Roe EJ, Terndrup TE. Two patients subdued with a TASER® device: cases and review of complications. J Emerg Med 2011; 40:28.</a></li><li><a class="nounderline abstract_t">Gleason JB, Ahmad I. TASER(®) Electronic Control Device-Induced Rhabdomyolysis and Renal Failure: A Case Report. J Clin Diagn Res 2015; 9:HD01.</a></li><li><a class="nounderline abstract_t">Bozeman WP, Hauda WE 2nd, Heck JJ, et al. Safety and injury profile of conducted electrical weapons used by law enforcement officers against criminal suspects. Ann Emerg Med 2009; 53:480.</a></li></ol></div><div id="topicVersionRevision">Topic 16414 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17338959" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The syndrome of rhabdomyolysis: Pathophysiology and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19841484" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Rhabdomyolysis: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7078398" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The spectrum of rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16267412" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Rhabdomyolysis: an evaluation of 475 hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15774072" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19571284" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Rhabdomyolysis and acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25829882" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Rhabdomyolysis: pathogenesis, diagnosis, and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11870710" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Rhabdomyolysis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30630682" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9429338" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24000014" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A risk prediction score for kidney failure or mortality in rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27301374" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34276082" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Rhabdomyolysis: Revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039546" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Characteristics and thirty-day outcomes of emergency department patients with elevated creatine kinase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19534642" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24367578" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors for acute kidney injury in severe rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19529963" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Rhabdomyolysis: a review, with emphasis on the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17079586" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute pediatric rhabdomyolysis: causes and rates of renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24004920" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical spectrum of rhabdomyolysis presented to pediatric emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23564464" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Rhabdomyolysis in bariatric surgery: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26032930" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16679975" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Serum creatine kinase levels and renal function measures in exertional muscle damage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26060183" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Creatine Kinase, Coenzyme Q10, Race, and Risk of Rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30212225" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Black Race and Body Mass Index Are Risk Factors for Rhabdomyolysis and Acute Kidney Injury in Trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26034592" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Disaster nephrology: a new concept for an old problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20783577" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Crush Injuries with Impairment of Renal Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11007816" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute renal failure related to the crush syndrome: towards an era of seismo-nephrology?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11532107" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The Marmara earthquake: epidemiological analysis of the victims with nephrological problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14979336" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Crush injury and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5015592" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Drugs, coma, and myoglobinuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9498517" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pressure-induced rhabdomyolysis and acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32532456" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26200417" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Rhabdomyolysis after tourniquet use in proximal tibial osteotomy: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9632160" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2071638" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Rhabdomyolysis following total hip arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9124760" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Exaggerated lithotomy position-related rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1422711" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Reperfusion injury in skeletal muscle: a prospective study in patients with acute limb ischaemia and claudicants treated by revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28332112" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Perspectives on Exertional Rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8848649" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Rhabdomyolysis following electrical injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20965664" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Rhabdomyolysis and acute renal failure in severely burned patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8459879" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Acute renal failure following physical torture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3842165" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Rhabdomyolysis and myoglobinuria as manifestations of child abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26888609" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Fatal rhabdomyolysis after torture by reverse hanging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17666931" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Child physical abuse and rhabdomyolysis: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/751088" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Myoglobinuria, rhabdomyolysis and marathon running.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2882252" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Fatal rhabdomyolysis in marathon runner.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34472544" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Exertional and CrossFit-Induced Rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30846355" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : CrossFit and rhabdomyolysis: A case series of 11 patients presenting at a single academic institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34193371" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Risk factors and future directions for preventing and diagnosing exertional rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17465608" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Exertional rhabdomyolysis and acute renal failure in marathon runners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1275626" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Incidence of acute exertional rhabdomyolysis. Serum myoglobin and enzyme levels as indicators of muscle injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4821779" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Environmental heat illness. An eclectic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12075060" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Heat stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5075551" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Exertional rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7036740" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Neuromuscular manifestations of electrolyte disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5032523" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : On the mechanism of rhabdomyolysis in potassium depletion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9834033" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : K+ is an endothelium-derived hyperpolarizing factor in rat arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10613417" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Adverse events associated with eccentric exercise protocols: six case studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5433281" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25678154" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Diagnostic evaluation of rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35369947" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Uncommon Causes of Rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35942668" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Recent advances in our understanding of genetic rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34957489" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2264536" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Recurrent childhood myoglobinuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2156480" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Metabolic causes of myoglobinuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Neuromuscular notes: Diagnosing metabolic myopathies</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27922496" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Metabolic Myopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29223996" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Metabolic myopathies: a practical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26810512" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Rhabdomyolysis featuring muscular dystrophies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27312022" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1178025" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Fuel homeostasis in exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6121542" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10487413" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Rhabdomyolysis associated with near-drowning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29989059" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Acute Renal Failure Following Near-Drowning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29382405" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Next-Generation Sequencing to Diagnose Muscular Dystrophy, Rhabdomyolysis, and HyperCKemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21498932" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2679245" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Drug- and toxin-induced rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8393995" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Drug-induced rhabdomyolysis--mechanisms and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19078495" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Rhabdomyolysis associated with nutritional supplement use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19139478" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Rhabdomyolysis associated with the nutritional supplement Hydroxycut.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22101980" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : In sickness and in health: the widespread application of creatine supplementation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18652082" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Safety of creatine supplementation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9274441" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Rhabdomyolysis and renal function impairment after isolated limb perfusion--comparison between the effects of perfusion with rhTNF alpha and a 'triple-drug' regimen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9548605" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Toxicity and morbidity of isolated limb perfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9631832" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Snake bite, rhabdomyolysis, and renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16434468" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Collett's snake (Pseudechis colletti) envenoming in snake handlers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18974586" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Wasp sting: an unusual fatal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16396886" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Massive honey bee envenomation-induced rhabdomyolysis in an adolescent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11556299" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Wild-mushroom intoxication as a cause of rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11576904" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Rhabdomyolysis: an unusual feature with mushroom poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15699848" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17192123" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : New syndromes in mushroom poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22382564" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Haff disease after eating crayfish in east China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23642345" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : A past Haff disease outbreak associated with eating freshwater pomfret in South China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9883771" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Haff disease associated with eating buffalo fish--United States, 1997.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23970182" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Rhabdomyolysis after fish consumption: Haff's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30451016" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Outbreak of Haff disease caused by consumption of crayfish (Procambarus clarkii) in nanjing, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10074634" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : [Epidemic rhabdomyolysis due to the eating of quail. A clinical, epidemiological and experimental study].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12005014" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Rhabdomyolysis of infectious and noninfectious causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8842914" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Severe rhabdomyolysis following a viral illness: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8729203" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Infectious etiologies of rhabdomyolysis: three case reports and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6292801" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Myoglobinuria associated with parainfluenza type 2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/213404" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Fatal rhabdomyolysis associated with parainfluenza type 3 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32584414" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Rhabdomyolysis as the main manifestation of coronavirus disease 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32690987" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Rhabdomyolysis as a manifestation of a severe case of COVID-19: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32197060" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Rhabdomyolysis as Potential Late Complication Associated with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32382463" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33153641" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Clinical Characteristics, Diagnosis, and Outcomes of 6 Patients With COVID-19 Infection and Rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/666478" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Tropical pyomyositis and myoglobinuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15800232" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Case records of the Massachusetts General Hospital. Case 10-2005. A 73-year-old man with weakness and pain in the legs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33863612" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Rhabdomyolysis and Multisystem Organ Failure Due to Fulminant Ehrlichiosis Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8377801" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Rhabdomyolysis in Malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15772274" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Rhabdomyolysis and acute renal failure in Plasmodium falciparum malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7387285" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Legionnaires' disease associated with rhabdomyolysis and myoglobinuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2801740" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Rhabdomyolysis in pneumococcal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6838149" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Acute renal failure in toxic shock syndrome owing to rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7442320" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1756765" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/686940" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Primary aldosteronism presenting as myoglobinuric acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1580292" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1580291" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Hypophosphatemia and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2294777" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Rhabdomyolysis in the hyperosmolal state.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7736901" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Rhabdomyolysis in diabetic emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14655521" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Rhabdomyolysis in diabetic ketoacidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8322842" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Rhabdomyolysis in a patient with hypocalcemia due to hypoparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3107377" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Psychogenic polydipsia with hyponatremia: report of eleven cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8430683" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Transient exercise-induced water intoxication and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1573339" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Hypernatremia and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17979621" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Hypernatraemia and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6486150" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Rhabdomyolysis in thyroid storm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2241450" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8469353" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Fulminant rhabdomyolysis in a patient with dermatomyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/286177" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Myoglobinuria and acute renal failure with acute polymyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15985512" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Recurrent rhabdomyolysis and myoglobinuric acute renal failure in a patient with polymyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28756023" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28842307" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean to Calabria, Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8420722" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Rhabdomyolysis associated with status asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8355028" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : A syndrome of acute severe muscle necrosis in intensive care unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8325053" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15778826" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : [Systemic capillary leak syndrome causes a compartment syndrome of both lower legs and a forearm. A case report with a review of the literature].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12048649" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15301690" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18439781" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Two patients subdued with a TASER®device: cases and review of complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26557540" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : TASER(®) Electronic Control Device-Induced Rhabdomyolysis and Renal Failure: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19157651" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Safety and injury profile of conducted electrical weapons used by law enforcement officers against criminal suspects.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
